| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 6.94e-09 | 17 | 84 | 5 | GO:0005132 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 2.48e-06 | 7 | 84 | 3 | GO:0001517 | |
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 5.23e-05 | 3 | 84 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | keratan sulfotransferase activity | 1.04e-04 | 4 | 84 | 2 | GO:0045130 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.04e-04 | 4 | 84 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.95e-04 | 27 | 84 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | primary methylamine oxidase activity | 6.18e-04 | 9 | 84 | 2 | GO:0008131 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 6.40e-04 | 93 | 84 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | aldehyde-lyase activity | 9.38e-04 | 11 | 84 | 2 | GO:0016832 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 1.12e-03 | 12 | 84 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.12e-03 | 12 | 84 | 2 | GO:0016175 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 6.09e-09 | 63 | 83 | 7 | GO:0043331 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.81e-08 | 21 | 83 | 5 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 3.74e-08 | 24 | 83 | 5 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 8.53e-08 | 28 | 83 | 5 | GO:0042501 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 8.75e-08 | 55 | 83 | 6 | GO:0043330 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 7.07e-07 | 42 | 83 | 5 | GO:0002323 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 1.20e-06 | 85 | 83 | 6 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 1.29e-06 | 86 | 83 | 6 | GO:0071357 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.91e-06 | 92 | 83 | 6 | GO:0034340 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 6.02e-06 | 112 | 83 | 6 | GO:0140888 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.08e-05 | 124 | 83 | 6 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.08e-05 | 124 | 83 | 6 | GO:0042100 | |
| GeneOntologyBiologicalProcess | cellular response to increased oxygen levels | 1.35e-05 | 12 | 83 | 3 | GO:0036295 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 1.91e-05 | 137 | 83 | 6 | GO:0033135 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 3.14e-05 | 90 | 83 | 5 | GO:0098586 | |
| GeneOntologyBiologicalProcess | keratan sulfate biosynthetic process | 3.39e-05 | 16 | 83 | 3 | GO:0018146 | |
| GeneOntologyBiologicalProcess | keratan sulfate metabolic process | 4.91e-05 | 18 | 83 | 3 | GO:0042339 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 5.47e-05 | 101 | 83 | 5 | GO:0033138 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine metabolic process | 6.82e-05 | 20 | 83 | 3 | GO:0006044 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 7.93e-05 | 21 | 83 | 3 | GO:0090083 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 9.37e-05 | 59 | 83 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 9.55e-05 | 4 | 83 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.21e-04 | 63 | 83 | 4 | GO:0050691 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen levels | 1.36e-04 | 195 | 83 | 6 | GO:0071453 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 1.48e-04 | 198 | 83 | 6 | GO:0007259 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.50e-04 | 125 | 83 | 5 | GO:0046425 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | IFNB1 FOXO1 FLNA TMEM259 INPP5K DUOX2 GRIA1 GRIA2 RAET1E IFNA4 IFNA7 STAT2 IFNA10 SLC27A4 IFNA17 | 1.51e-04 | 1272 | 83 | 15 | GO:1901698 |
| GeneOntologyBiologicalProcess | cellular response to hyperoxia | 1.59e-04 | 5 | 83 | 2 | GO:0071455 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 1.61e-04 | 201 | 83 | 6 | GO:0030183 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.71e-04 | 27 | 83 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | response to increased oxygen levels | 1.71e-04 | 27 | 83 | 3 | GO:0036296 | |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 1.91e-04 | 28 | 83 | 3 | GO:0071359 | |
| GeneOntologyBiologicalProcess | glucosamine-containing compound metabolic process | 2.13e-04 | 29 | 83 | 3 | GO:1901071 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 2.37e-04 | 216 | 83 | 6 | GO:0097696 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | IFNB1 FLNA INPP5K DUOX2 GRIA1 RAET1E IRX1 CBL MMP15 IFNA4 IFNA7 IFNA10 IFNA17 | 2.70e-04 | 1048 | 83 | 13 | GO:0014070 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 2.81e-04 | 143 | 83 | 5 | GO:1904892 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 3.14e-04 | 33 | 83 | 3 | GO:0070841 | |
| GeneOntologyBiologicalProcess | response to starvation | 3.25e-04 | 229 | 83 | 6 | GO:0042594 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 3.29e-04 | 148 | 83 | 5 | GO:0002286 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 4.79e-04 | 90 | 83 | 4 | GO:0050688 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 5.58e-04 | 40 | 83 | 3 | GO:1990806 | |
| GeneOntologyBiologicalProcess | fructose 1,6-bisphosphate metabolic process | 5.65e-04 | 9 | 83 | 2 | GO:0030388 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 7.13e-04 | 100 | 83 | 4 | GO:1903510 | |
| GeneOntologyBiologicalProcess | response to antibiotic | 7.39e-04 | 44 | 83 | 3 | GO:0046677 | |
| GeneOntologyBiologicalProcess | amino sugar metabolic process | 8.97e-04 | 47 | 83 | 3 | GO:0006040 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 1.03e-03 | 12 | 83 | 2 | GO:0090084 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 1.07e-03 | 50 | 83 | 3 | GO:0042554 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 5.25e-05 | 18 | 86 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | perisynaptic space | 9.98e-05 | 4 | 86 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.69e-04 | 306 | 86 | 7 | GO:0005802 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 4.78e-04 | 443 | 86 | 8 | GO:0098791 | |
| Domain | Interferon_alpha/beta/delta | 9.67e-09 | 17 | 84 | 5 | IPR000471 | |
| Domain | Interferon | 9.67e-09 | 17 | 84 | 5 | PF00143 | |
| Domain | IFabd | 9.67e-09 | 17 | 84 | 5 | SM00076 | |
| Domain | INTERFERON_A_B_D | 9.67e-09 | 17 | 84 | 5 | PS00252 | |
| Domain | 4_helix_cytokine-like_core | 1.00e-06 | 74 | 84 | 6 | IPR009079 | |
| Domain | - | 2.95e-06 | 50 | 84 | 5 | 1.20.1250.10 | |
| Domain | Carbohydrate_sulfotransferase | 3.03e-06 | 7 | 84 | 3 | IPR016469 | |
| Domain | 4_helix_cytokine_core | 3.26e-06 | 51 | 84 | 5 | IPR012351 | |
| Domain | - | 5.98e-05 | 3 | 84 | 2 | 2.70.98.20 | |
| Domain | Cu_amine_oxidase_N3 | 5.98e-05 | 3 | 84 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 5.98e-05 | 3 | 84 | 2 | IPR015800 | |
| Domain | FBA_I | 5.98e-05 | 3 | 84 | 2 | IPR000741 | |
| Domain | Cu_amine_oxidN2 | 5.98e-05 | 3 | 84 | 2 | PF02727 | |
| Domain | Cu_amine_oxidN3 | 5.98e-05 | 3 | 84 | 2 | PF02728 | |
| Domain | Cu_amine_oxidase_N-reg | 5.98e-05 | 3 | 84 | 2 | IPR016182 | |
| Domain | Cu_amine_oxid | 5.98e-05 | 3 | 84 | 2 | PF01179 | |
| Domain | Glycolytic | 5.98e-05 | 3 | 84 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 5.98e-05 | 3 | 84 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 5.98e-05 | 3 | 84 | 2 | PS00158 | |
| Domain | Cu_amine_oxidase_C | 5.98e-05 | 3 | 84 | 2 | IPR015798 | |
| Domain | COPPER_AMINE_OXID_1 | 5.98e-05 | 3 | 84 | 2 | PS01164 | |
| Domain | COPPER_AMINE_OXID_2 | 5.98e-05 | 3 | 84 | 2 | PS01165 | |
| Domain | Cu_amine_oxidase | 1.19e-04 | 4 | 84 | 2 | IPR000269 | |
| Domain | Laminin_G | 1.34e-04 | 58 | 84 | 4 | IPR001791 | |
| Domain | Actinin_actin-bd_CS | 1.46e-04 | 23 | 84 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 1.46e-04 | 23 | 84 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.46e-04 | 23 | 84 | 3 | PS00019 | |
| Domain | CH | 2.09e-04 | 65 | 84 | 4 | SM00033 | |
| Domain | CH | 2.78e-04 | 70 | 84 | 4 | PF00307 | |
| Domain | - | 2.94e-04 | 71 | 84 | 4 | 1.10.418.10 | |
| Domain | CH | 3.27e-04 | 73 | 84 | 4 | PS50021 | |
| Domain | CH-domain | 3.63e-04 | 75 | 84 | 4 | IPR001715 | |
| Domain | NAD_binding_6 | 4.14e-04 | 7 | 84 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 4.14e-04 | 7 | 84 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 4.14e-04 | 7 | 84 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 4.14e-04 | 7 | 84 | 2 | IPR013121 | |
| Domain | Sulfotransferase_dom | 5.63e-04 | 36 | 84 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 5.63e-04 | 36 | 84 | 3 | PF00685 | |
| Domain | ANF_lig-bd_rcpt | 6.11e-04 | 37 | 84 | 3 | IPR001828 | |
| Domain | ANF_receptor | 6.11e-04 | 37 | 84 | 3 | PF01094 | |
| Domain | LAM_G_DOMAIN | 6.61e-04 | 38 | 84 | 3 | PS50025 | |
| Domain | Peripla_BP_I | 7.14e-04 | 39 | 84 | 3 | IPR028082 | |
| Domain | Laminin_G_2 | 7.69e-04 | 40 | 84 | 3 | PF02210 | |
| Domain | - | 8.88e-04 | 95 | 84 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.02e-03 | 44 | 84 | 3 | SM00282 | |
| Domain | Rap_GAP_dom | 1.07e-03 | 11 | 84 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.07e-03 | 11 | 84 | 2 | PS50085 | |
| Domain | Ferric_reduct | 1.28e-03 | 12 | 84 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 1.28e-03 | 12 | 84 | 2 | IPR013130 | |
| Domain | Iontro_rcpt | 2.92e-03 | 18 | 84 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.92e-03 | 18 | 84 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 2.92e-03 | 18 | 84 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.92e-03 | 18 | 84 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.92e-03 | 18 | 84 | 2 | SM00918 | |
| Domain | Lig_chan | 2.92e-03 | 18 | 84 | 2 | PF00060 | |
| Domain | PBPe | 2.92e-03 | 18 | 84 | 2 | SM00079 | |
| Domain | ConA-like_dom | 3.09e-03 | 219 | 84 | 5 | IPR013320 | |
| Domain | Fd_Rdtase_FAD-bd | 3.25e-03 | 19 | 84 | 2 | IPR017927 | |
| Domain | FAD_FR | 3.25e-03 | 19 | 84 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 3.25e-03 | 19 | 84 | 2 | IPR017938 | |
| Domain | FA58C | 3.97e-03 | 21 | 84 | 2 | SM00231 | |
| Domain | FA58C_3 | 3.97e-03 | 21 | 84 | 2 | PS50022 | |
| Domain | FA58C_1 | 3.97e-03 | 21 | 84 | 2 | PS01285 | |
| Domain | FA58C_2 | 3.97e-03 | 21 | 84 | 2 | PS01286 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.20e-10 | 19 | 60 | 6 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 4.39e-10 | 23 | 60 | 6 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 4.39e-10 | 23 | 60 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 5.83e-10 | 24 | 60 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 9.91e-10 | 26 | 60 | 6 | M982 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 3.12e-09 | 31 | 60 | 6 | M39897 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 5.64e-09 | 34 | 60 | 6 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 6.78e-09 | 35 | 60 | 6 | M48246 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 7.01e-09 | 17 | 60 | 5 | M47564 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 9.65e-09 | 37 | 60 | 6 | M39785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 9.68e-09 | 18 | 60 | 5 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.74e-08 | 20 | 60 | 5 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 2.94e-08 | 22 | 60 | 5 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 2.94e-08 | 22 | 60 | 5 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 4.71e-08 | 24 | 60 | 5 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 4.71e-08 | 24 | 60 | 5 | M47782 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 1.07e-07 | 28 | 60 | 5 | MM1378 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.55e-07 | 30 | 60 | 5 | M936 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.84e-07 | 31 | 60 | 5 | M47964 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 2.55e-07 | 33 | 60 | 5 | MM1379 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 6.07e-07 | 39 | 60 | 5 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 7.85e-07 | 41 | 60 | 5 | MM1493 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 9.32e-07 | 78 | 60 | 6 | M973 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.10e-06 | 19 | 60 | 4 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.68e-06 | 21 | 60 | 4 | M47909 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 3.38e-06 | 151 | 60 | 7 | M39801 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 3.48e-06 | 55 | 60 | 5 | M11844 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.58e-06 | 98 | 60 | 6 | M48247 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 4.02e-06 | 155 | 60 | 7 | M17411 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.15e-05 | 120 | 60 | 6 | M48233 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.24e-05 | 71 | 60 | 5 | M15913 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 1.41e-05 | 35 | 60 | 4 | M6382 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 1.42e-05 | 73 | 60 | 5 | M39837 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.53e-05 | 126 | 60 | 6 | M45009 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.36e-05 | 136 | 60 | 6 | M42547 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 2.46e-05 | 137 | 60 | 6 | M5669 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.50e-05 | 82 | 60 | 5 | M1002 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.56e-05 | 138 | 60 | 6 | MM15635 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 3.33e-05 | 87 | 60 | 5 | MM15915 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 6.89e-05 | 52 | 60 | 4 | M13103 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 7.16e-05 | 102 | 60 | 5 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 7.50e-05 | 103 | 60 | 5 | M39434 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.52e-04 | 273 | 60 | 7 | M983 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.65e-04 | 65 | 60 | 4 | M272 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 2.01e-04 | 127 | 60 | 5 | M42533 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.11e-04 | 288 | 60 | 7 | M16864 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 2.23e-04 | 28 | 60 | 3 | M670 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 2.23e-04 | 28 | 60 | 3 | MM14798 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 2.23e-04 | 204 | 60 | 6 | M45011 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.74e-04 | 36 | 60 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.74e-04 | 36 | 60 | 3 | MM14632 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 5.30e-04 | 88 | 60 | 4 | M16004 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 6.29e-04 | 9 | 60 | 2 | M22056 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 7.69e-04 | 170 | 60 | 5 | M941 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 9.02e-04 | 367 | 60 | 7 | M48346 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.00e-03 | 271 | 60 | 6 | MM15406 | |
| Pathway | REACTOME_KILLING_MECHANISMS | 1.14e-03 | 12 | 60 | 2 | M29844 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 1.66e-03 | 299 | 60 | 6 | M41727 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE | 1.81e-03 | 15 | 60 | 2 | M3042 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.85e-03 | 123 | 60 | 4 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 2.02e-03 | 126 | 60 | 4 | M695 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 2.06e-03 | 16 | 60 | 2 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 2.33e-03 | 17 | 60 | 2 | M5488 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.56e-03 | 326 | 60 | 6 | MM15917 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 2.61e-03 | 18 | 60 | 2 | M48098 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.11e-03 | 339 | 60 | 6 | M39736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.55e-03 | 21 | 60 | 2 | M838 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 3.76e-03 | 472 | 60 | 7 | MM14539 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 3.90e-03 | 22 | 60 | 2 | M39795 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 3.90e-03 | 22 | 60 | 2 | MM15887 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.90e-03 | 22 | 60 | 2 | MM15104 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 4.26e-03 | 23 | 60 | 2 | M39814 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 4.26e-03 | 23 | 60 | 2 | M27949 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 4.63e-03 | 24 | 60 | 2 | M27553 | |
| Pathway | WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE | 4.63e-03 | 24 | 60 | 2 | M40055 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 5.02e-03 | 25 | 60 | 2 | MM15269 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 5.02e-03 | 25 | 60 | 2 | M47623 | |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 8.91e-12 | 20 | 89 | 6 | 11694501 | |
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 7.65e-11 | 12 | 89 | 5 | 21320124 | |
| Pubmed | 7.65e-11 | 12 | 89 | 5 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 7.65e-11 | 12 | 89 | 5 | 8304945 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 7.65e-11 | 12 | 89 | 5 | 32016282 | |
| Pubmed | 7.65e-11 | 12 | 89 | 5 | 30967261 | ||
| Pubmed | 7.65e-11 | 12 | 89 | 5 | 23747509 | ||
| Pubmed | 7.65e-11 | 12 | 89 | 5 | 17434974 | ||
| Pubmed | 7.65e-11 | 12 | 89 | 5 | 7601556 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 1.24e-10 | 13 | 89 | 5 | 3973562 | |
| Pubmed | 1.24e-10 | 13 | 89 | 5 | 12050368 | ||
| Pubmed | 1.24e-10 | 13 | 89 | 5 | 2993652 | ||
| Pubmed | 1.93e-10 | 14 | 89 | 5 | 14983024 | ||
| Pubmed | 1.93e-10 | 14 | 89 | 5 | 1442307 | ||
| Pubmed | 1.93e-10 | 14 | 89 | 5 | 19620305 | ||
| Pubmed | 1.93e-10 | 14 | 89 | 5 | 15240719 | ||
| Pubmed | 1.93e-10 | 14 | 89 | 5 | 2987811 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 1.93e-10 | 14 | 89 | 5 | 7654369 | |
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 1.93e-10 | 14 | 89 | 5 | 7532202 | |
| Pubmed | 2.88e-10 | 15 | 89 | 5 | 33615540 | ||
| Pubmed | 2.88e-10 | 15 | 89 | 5 | 15684736 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 2.88e-10 | 15 | 89 | 5 | 8661419 | |
| Pubmed | 2.88e-10 | 15 | 89 | 5 | 15972639 | ||
| Pubmed | 4.18e-10 | 16 | 89 | 5 | 3100390 | ||
| Pubmed | Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. | 4.18e-10 | 16 | 89 | 5 | 21115688 | |
| Pubmed | 4.18e-10 | 16 | 89 | 5 | 16311601 | ||
| Pubmed | 5.91e-10 | 17 | 89 | 5 | 22814248 | ||
| Pubmed | Type I IFN substitutes for T cell help during viral infections. | 5.91e-10 | 17 | 89 | 5 | 21160039 | |
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 1.11e-09 | 19 | 89 | 5 | 1708818 | |
| Pubmed | Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. | 1.47e-09 | 20 | 89 | 5 | 15568025 | |
| Pubmed | 2.49e-09 | 22 | 89 | 5 | 7913356 | ||
| Pubmed | 3.18e-09 | 23 | 89 | 5 | 9225992 | ||
| Pubmed | PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response. | 4.01e-09 | 24 | 89 | 5 | 35037428 | |
| Pubmed | 5.00e-09 | 25 | 89 | 5 | 27183626 | ||
| Pubmed | Modulation of HIV-1 transcription by cytokines and chemokines. | 5.00e-09 | 25 | 89 | 5 | 16375755 | |
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 6.17e-09 | 26 | 89 | 5 | 38744293 | |
| Pubmed | The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. | 7.56e-09 | 27 | 89 | 5 | 25456137 | |
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 7.56e-09 | 27 | 89 | 5 | 30936491 | |
| Pubmed | Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. | 7.56e-09 | 27 | 89 | 5 | 33165593 | |
| Pubmed | Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. | 9.19e-09 | 28 | 89 | 5 | 17277142 | |
| Pubmed | 9.19e-09 | 28 | 89 | 5 | 15481145 | ||
| Pubmed | 1.11e-08 | 29 | 89 | 5 | 7507352 | ||
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.30e-08 | 11 | 89 | 4 | 8389790 | |
| Pubmed | 1.30e-08 | 11 | 89 | 4 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.30e-08 | 11 | 89 | 4 | 6444699 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.30e-08 | 11 | 89 | 4 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.30e-08 | 11 | 89 | 4 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.30e-08 | 11 | 89 | 4 | 15795237 | |
| Pubmed | 1.30e-08 | 11 | 89 | 4 | 9794439 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.30e-08 | 11 | 89 | 4 | 10448195 | |
| Pubmed | 1.30e-08 | 11 | 89 | 4 | 25310498 | ||
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.30e-08 | 11 | 89 | 4 | 19120292 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 11278593 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 16565497 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 22685550 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 3017340 | ||
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.95e-08 | 12 | 89 | 4 | 33123150 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 11846978 | ||
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.95e-08 | 12 | 89 | 4 | 27988795 | |
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.95e-08 | 12 | 89 | 4 | 8760352 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.95e-08 | 12 | 89 | 4 | 17512142 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 9425112 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.95e-08 | 12 | 89 | 4 | 1886773 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 1.95e-08 | 12 | 89 | 4 | 1422836 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 1.95e-08 | 12 | 89 | 4 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.95e-08 | 12 | 89 | 4 | 7925651 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.95e-08 | 12 | 89 | 4 | 7530016 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 17277125 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 9794206 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.95e-08 | 12 | 89 | 4 | 7684767 | |
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 1.95e-08 | 12 | 89 | 4 | 1360280 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 1.95e-08 | 12 | 89 | 4 | 26277892 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 1.95e-08 | 12 | 89 | 4 | 18716002 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 17451966 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 25897172 | ||
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.95e-08 | 12 | 89 | 4 | 16611902 | |
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 1.95e-08 | 12 | 89 | 4 | 8672140 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.95e-08 | 12 | 89 | 4 | 22912583 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.95e-08 | 12 | 89 | 4 | 3758677 | |
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 19406830 | ||
| Pubmed | 1.95e-08 | 12 | 89 | 4 | 8245849 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 2.81e-08 | 13 | 89 | 4 | 12930842 | |
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 23804712 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 22431588 | ||
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 2.81e-08 | 13 | 89 | 4 | 2014240 | |
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 18005734 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 2.81e-08 | 13 | 89 | 4 | 2987810 | |
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 2.81e-08 | 13 | 89 | 4 | 6094686 | |
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 19130550 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 1655578 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 21469099 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 2471809 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 22739040 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 21263073 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 8438572 | ||
| Pubmed | 2.81e-08 | 13 | 89 | 4 | 38660315 | ||
| Cytoband | 9p22 | 1.62e-07 | 25 | 89 | 4 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 4.59e-06 | 124 | 89 | 5 | chr9p21 | |
| GeneFamily | Interferons | 3.72e-08 | 32 | 54 | 5 | 598 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 5.23e-05 | 4 | 54 | 2 | 1200 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.82e-04 | 37 | 54 | 3 | 763 | |
| GeneFamily | Cadherin related | 1.16e-03 | 17 | 54 | 2 | 24 | |
| GeneFamily | Carboxypeptidases | 1.77e-03 | 21 | 54 | 2 | 1321 | |
| GeneFamily | Nudix hydrolase family | 2.32e-03 | 24 | 54 | 2 | 667 | |
| GeneFamily | Phosphoinositide phosphatases | 4.10e-03 | 32 | 54 | 2 | 1079 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.12e-07 | 39 | 89 | 5 | M41095 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 2.76e-06 | 29 | 89 | 4 | MM586 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 7.93e-06 | 80 | 89 | 5 | MM1229 | |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 3.99e-05 | 56 | 89 | 4 | M10332 | |
| Coexpression | MODY_HIPPOCAMPUS_POSTNATAL | 3.99e-05 | 56 | 89 | 4 | MM648 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_DN | 5.78e-05 | 197 | 89 | 6 | M5196 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.11e-06 | 243 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.18e-08 | 100 | 89 | 6 | 3a7e5469de88745ac455c35deeb859d68dce73fa | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.18e-08 | 100 | 89 | 6 | 187e31d4186b82a37569b98d83e4813017cc2ddd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-05 | 157 | 89 | 5 | 921805932f7974d37aed547861d555b07f30aba6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 170 | 89 | 5 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.68e-05 | 175 | 89 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.68e-05 | 175 | 89 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-Gpr17_(Bmp4)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.68e-05 | 86 | 89 | 4 | eb2b9e98ff97371f497ee1709848a2caaa46ed3d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-Gpr17_(Bmp4)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.68e-05 | 86 | 89 | 4 | 02ea5219e2faded2b50b96d41861e4f8a558e4e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 177 | 89 | 5 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 177 | 89 | 5 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-05 | 181 | 89 | 5 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 183 | 89 | 5 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.17e-05 | 192 | 89 | 5 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 193 | 89 | 5 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 4.38e-05 | 194 | 89 | 5 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 198 | 89 | 5 | 77288df94286382170a266474ab85960519e8449 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 198 | 89 | 5 | 2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-05 | 198 | 89 | 5 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.94e-05 | 199 | 89 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| Drug | HMPV | 4.36e-10 | 25 | 87 | 6 | CID004444603 | |
| Drug | gunacin | 1.41e-09 | 14 | 87 | 5 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 2.11e-09 | 15 | 87 | 5 | CID000125229 | |
| Drug | podophyllin | 5.97e-09 | 18 | 87 | 5 | CID011979494 | |
| Drug | Nyco | 5.97e-09 | 18 | 87 | 5 | CID000071618 | |
| Drug | Yfrkd | 6.90e-09 | 7 | 87 | 4 | CID000129984 | |
| Drug | 1hiv | 1.38e-08 | 8 | 87 | 4 | CID005479205 | |
| Drug | Chebi:36708 | 1.38e-08 | 8 | 87 | 4 | CID011966289 | |
| Drug | Iem 1460 | 1.38e-08 | 8 | 87 | 4 | CID003248290 | |
| Drug | Sesquimustard | 1.42e-08 | 43 | 87 | 6 | CID000019092 | |
| Drug | AC1MMF4B | 1.80e-08 | 77 | 87 | 7 | CID003260010 | |
| Drug | formosanin C | 1.81e-08 | 22 | 87 | 5 | CID000073597 | |
| Drug | Hiltonol | 2.31e-08 | 23 | 87 | 5 | CID000431963 | |
| Drug | cycloferon | 2.91e-08 | 24 | 87 | 5 | CID000038072 | |
| Drug | hycanthone | 3.63e-08 | 25 | 87 | 5 | CID000003634 | |
| Drug | pipobroman | 4.10e-08 | 10 | 87 | 4 | CID000004842 | |
| Drug | ABMP | 4.48e-08 | 26 | 87 | 5 | CID000080567 | |
| Drug | inosiplex | 5.48e-08 | 27 | 87 | 5 | CID000037510 | |
| Drug | flesinoxan | 6.43e-08 | 11 | 87 | 4 | CID000057347 | |
| Drug | DZNep | 9.58e-08 | 30 | 87 | 5 | CID000073087 | |
| Drug | poly rI:rC | 9.58e-08 | 30 | 87 | 5 | CID011979660 | |
| Drug | AC1L1U53 | 1.11e-07 | 60 | 87 | 6 | CID000060907 | |
| Drug | CHEMBL466993 | 1.35e-07 | 32 | 87 | 5 | CID005320808 | |
| Drug | R 842 | 1.38e-07 | 13 | 87 | 4 | CID000130714 | |
| Drug | AC1O52EF | 1.38e-07 | 13 | 87 | 4 | CID006450817 | |
| Drug | carprofen | 1.85e-07 | 34 | 87 | 5 | CID000002581 | |
| Drug | Lanicemine | 1.93e-07 | 14 | 87 | 4 | CID003038485 | |
| Drug | sunifiram | 2.15e-07 | 4 | 87 | 3 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 2.15e-07 | 4 | 87 | 3 | CID011105661 | |
| Drug | 3-isoxazolol | 2.15e-07 | 4 | 87 | 3 | CID009964065 | |
| Drug | barium iodide | 2.15e-07 | 4 | 87 | 3 | CID000083684 | |
| Drug | tilorone | 2.15e-07 | 35 | 87 | 5 | CID000005475 | |
| Drug | bromcresol green | 2.15e-07 | 110 | 87 | 7 | CID000006451 | |
| Drug | MCNU | 2.49e-07 | 36 | 87 | 5 | CID000071741 | |
| Drug | NSC-218321 | 2.75e-07 | 114 | 87 | 7 | CID000004739 | |
| Drug | pyran | 2.87e-07 | 37 | 87 | 5 | CID000033703 | |
| Drug | FMAU | 2.87e-07 | 37 | 87 | 5 | CID000072327 | |
| Drug | N6-methyl-(R)-roscovitine | 3.07e-07 | 71 | 87 | 6 | CID005289296 | |
| Drug | anagrelide | 3.30e-07 | 38 | 87 | 5 | CID000002182 | |
| Drug | isofagomine lactam | 3.77e-07 | 39 | 87 | 5 | CID000448980 | |
| Drug | PPNDS | 4.56e-07 | 17 | 87 | 4 | CID005961627 | |
| Drug | YNK01 | 4.56e-07 | 17 | 87 | 4 | CID000084071 | |
| Drug | acyclovir | 4.88e-07 | 124 | 87 | 7 | CID000002022 | |
| Drug | poly I | 4.89e-07 | 250 | 87 | 9 | CID000000797 | |
| Drug | AC1L1YEG | 5.36e-07 | 5 | 87 | 3 | CID000063114 | |
| Drug | Chicago acid | 5.36e-07 | 5 | 87 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 5.36e-07 | 5 | 87 | 3 | CID011334126 | |
| Drug | 1-BCP | 5.36e-07 | 5 | 87 | 3 | CID000001370 | |
| Drug | B132 | 5.36e-07 | 5 | 87 | 3 | CID002734031 | |
| Drug | irampanel | 5.36e-07 | 5 | 87 | 3 | CID003038472 | |
| Drug | LY395153 | 5.36e-07 | 5 | 87 | 3 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 5.36e-07 | 5 | 87 | 3 | CID000107978 | |
| Drug | 5-h PCA | 5.36e-07 | 5 | 87 | 3 | CID000129091 | |
| Drug | 1 ind | 5.52e-07 | 42 | 87 | 5 | CID003037877 | |
| Drug | hydralazine | 5.75e-07 | 186 | 87 | 8 | CID000003637 | |
| Drug | p203 | 5.84e-07 | 18 | 87 | 4 | CID000019228 | |
| Drug | NSC 312887 | 6.23e-07 | 43 | 87 | 5 | CID000003368 | |
| Drug | m-cresol | 7.79e-07 | 83 | 87 | 6 | CID000000342 | |
| Drug | AC1L9AL3 | 8.79e-07 | 46 | 87 | 5 | CID000441122 | |
| Drug | Ciluprevir [USAN] | 9.19e-07 | 20 | 87 | 4 | CID006450803 | |
| Drug | val-mCyd | 9.19e-07 | 20 | 87 | 4 | CID006918726 | |
| Drug | entecavir | 9.80e-07 | 47 | 87 | 5 | CID000153941 | |
| Drug | HCV-371 | 1.07e-06 | 6 | 87 | 3 | CID003013096 | |
| Drug | YM928 | 1.07e-06 | 6 | 87 | 3 | CID006918393 | |
| Drug | 2cmo | 1.07e-06 | 6 | 87 | 3 | CID006914597 | |
| Drug | Halt | 1.13e-06 | 21 | 87 | 4 | CID000094635 | |
| Drug | L DO | 1.13e-06 | 21 | 87 | 4 | CID000097725 | |
| Drug | adefovir dipivoxil | 1.21e-06 | 49 | 87 | 5 | CID000060871 | |
| Drug | isoflurane | 1.22e-06 | 279 | 87 | 9 | CID000003763 | |
| Drug | trifluorothymidine | 1.48e-06 | 51 | 87 | 5 | CID000006256 | |
| Drug | famciclovir | 1.64e-06 | 52 | 87 | 5 | CID000003324 | |
| Drug | bropirimine | 1.64e-06 | 52 | 87 | 5 | CID000065457 | |
| Drug | Ampligen | 1.80e-06 | 53 | 87 | 5 | CID000038077 | |
| Drug | 2H-1,2,4-benzothiadiazine | 1.87e-06 | 7 | 87 | 3 | CID000473368 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 1.87e-06 | 7 | 87 | 3 | CID000127988 | |
| Drug | thio-ATPA | 1.87e-06 | 7 | 87 | 3 | CID005289517 | |
| Drug | 13-methoxyibogamine | 1.98e-06 | 54 | 87 | 5 | CID000065749 | |
| Drug | AC1L1ZCT | 1.99e-06 | 24 | 87 | 4 | CID000038235 | |
| Drug | LB80380 | 2.37e-06 | 25 | 87 | 4 | CID006480442 | |
| Drug | m IU | 2.38e-06 | 56 | 87 | 5 | CID006852123 | |
| Drug | Beryllium | 2.38e-06 | 56 | 87 | 5 | CID000107649 | |
| Drug | oligoadenylate | 2.39e-06 | 157 | 87 | 7 | CID000107918 | |
| Drug | imidazoquinoline | 2.48e-06 | 101 | 87 | 6 | CID005351568 | |
| Drug | 5H-purin-2-amine | 2.62e-06 | 102 | 87 | 6 | CID000409844 | |
| Drug | TcNr | 2.79e-06 | 26 | 87 | 4 | CID000162010 | |
| Drug | Lps2 | 2.83e-06 | 58 | 87 | 5 | CID000454710 | |
| Drug | dipyridamole | 2.94e-06 | 162 | 87 | 7 | CID000003108 | |
| Drug | homoibotenic acid | 2.98e-06 | 8 | 87 | 3 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 2.98e-06 | 8 | 87 | 3 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 2.98e-06 | 8 | 87 | 3 | CID003614351 | |
| Drug | AC1LAD6M | 2.98e-06 | 8 | 87 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 2.98e-06 | 8 | 87 | 3 | CID010011375 | |
| Drug | VX-497 | 3.26e-06 | 27 | 87 | 4 | CID000153241 | |
| Drug | AC1NRD2B | 3.80e-06 | 28 | 87 | 4 | CID005289317 | |
| Drug | NSC141633 | 4.39e-06 | 29 | 87 | 4 | CID000003628 | |
| Drug | NM 108 | 4.39e-06 | 29 | 87 | 4 | CID000500901 | |
| Drug | 1m5b | 4.45e-06 | 9 | 87 | 3 | CID000447081 | |
| Drug | Ly294486 | 4.45e-06 | 9 | 87 | 3 | CID005311255 | |
| Drug | Telaprevir | 4.45e-06 | 9 | 87 | 3 | CID003010818 | |
| Drug | boceprevir | 4.45e-06 | 9 | 87 | 3 | CID010324367 | |
| Disease | carboxyethyl-GABA measurement | 2.51e-05 | 3 | 86 | 2 | EFO_0800059 | |
| Disease | X-24020 measurement | 8.35e-05 | 5 | 86 | 2 | EFO_0022128 | |
| Disease | electrocardiography, QT interval | 8.35e-05 | 5 | 86 | 2 | EFO_0004327, EFO_0004682 | |
| Disease | acisoga measurement | 1.75e-04 | 7 | 86 | 2 | EFO_0800068 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.32e-04 | 8 | 86 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | volumetric bone mineral density | 2.53e-04 | 42 | 86 | 3 | EFO_0007620 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.04e-04 | 53 | 86 | 3 | C4707243 | |
| Disease | N-acetyl-isoputreanine measurement | 6.41e-04 | 13 | 86 | 2 | EFO_0800107 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 8.76e-04 | 64 | 86 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | CCL5 measurement | 8.76e-04 | 64 | 86 | 3 | EFO_0005117 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 9.81e-04 | 16 | 86 | 2 | C4551479 | |
| Disease | central nervous system disease (implicated_via_orthology) | 9.81e-04 | 16 | 86 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Spondyloepiphyseal Dysplasia | 9.81e-04 | 16 | 86 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 9.81e-04 | 16 | 86 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 9.81e-04 | 16 | 86 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 9.81e-04 | 16 | 86 | 2 | C3541456 | |
| Disease | Van Buchem disease | 1.11e-03 | 17 | 86 | 2 | C0432272 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.39e-03 | 19 | 86 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Dyschondroplasias | 1.39e-03 | 19 | 86 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 1.39e-03 | 19 | 86 | 2 | C0029422 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.54e-03 | 20 | 86 | 2 | C0026760 | |
| Disease | seborrheic dermatitis | 1.54e-03 | 20 | 86 | 2 | EFO_1000764 | |
| Disease | congestive heart failure (is_marker_for) | 1.79e-03 | 82 | 86 | 3 | DOID:6000 (is_marker_for) | |
| Disease | bilirubin measurement | 1.87e-03 | 442 | 86 | 6 | EFO_0004570 | |
| Disease | glycerol measurement | 2.61e-03 | 26 | 86 | 2 | EFO_0010115 | |
| Disease | Glycogen Storage Disease | 2.81e-03 | 27 | 86 | 2 | C0017919 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWNHSSSFSGNASIL | 196 | Q9H0X4 | |
| RGDQSFWNSASFNTE | 786 | Q9BZ76 | |
| FASLGNLTFLSLQWN | 261 | P22792 | |
| AANTFDSFSGATWDL | 101 | O43310 | |
| WALTFSYGRALQASA | 296 | P09972 | |
| WALTFSYGRALQASA | 296 | P04075 | |
| AAASRANASFTWVAS | 286 | Q14832 | |
| SWSRFSYFIGSGNEN | 3436 | Q6V0I7 | |
| FSVFQSFLDESASGW | 3256 | Q8WXG9 | |
| NSLLFRWSGSGFINF | 3431 | Q8WXG9 | |
| ASWLSTAANFLSRSF | 266 | Q9NVT9 | |
| RDSWNFVFGQASLTD | 181 | Q86W34 | |
| GWSFAFRLRSSSGLQ | 321 | P19801 | |
| SWFTDSNNAIASLAF | 131 | Q9C0C7 | |
| VAAIFGTSRSWFANN | 581 | Q9H6U6 | |
| TCFGTDLNRNFNASW | 176 | Q8IVL8 | |
| QGSRVASSLWTFSFG | 326 | Q16853 | |
| FSLDTFNSSTWNFCS | 386 | O75355 | |
| ASWQFATNGEKSLLF | 136 | Q8TD07 | |
| TDNFAQSSCFGLRWF | 56 | P30039 | |
| SIWQFFSRLFSSSSN | 551 | O60271 | |
| ETGAFSWFNNLLTSL | 441 | Q9Y5S8 | |
| QSGSRLLFSAESFCW | 131 | O60568 | |
| SWLRQGFSINLTSFG | 46 | Q9Y442 | |
| QTFNLFSTEDSSAAW | 86 | P01566 | |
| NGLSLVIFSDWYNTS | 716 | Q14703 | |
| SYRDFLGTNWSSSAA | 86 | Q9BRQ3 | |
| VRSEGNTSSLWNFSA | 51 | Q8TAV5 | |
| WTFSSTDLHGNNLFL | 241 | P51511 | |
| FSGVSNIFSFWGDSR | 991 | Q12809 | |
| SNQISHWDLGSSFFF | 136 | O95069 | |
| WSDALRSFSGGQLAS | 191 | Q9NRD8 | |
| DWSSTFFSFLNPDNI | 5401 | Q5CZC0 | |
| SESTNEFGIFNSLWF | 586 | P42262 | |
| FSFGSWNLSDRFNFT | 576 | O60486 | |
| GIQAFRNSFSSSWFH | 31 | Q9BW91 | |
| QTFNLFSTEDSSAAW | 86 | P01567 | |
| ATFTFTWAFQRTNQG | 561 | A8MWY0 | |
| QISEFSFLGSNWDSF | 896 | Q9NYA4 | |
| SSSFLDSGWRDLFSR | 681 | Q6VY07 | |
| LWAASGSSAQLFNLT | 56 | Q6V1P9 | |
| DQGLLNSFFRNWSTT | 196 | O15488 | |
| ATRLAAASWGSGFFS | 141 | Q8NGX9 | |
| DFDNWSTFRPRTSSN | 306 | Q12778 | |
| SSYFRALFTSGWNNT | 61 | Q6JEL2 | |
| TNFSRDWQSGRALGA | 186 | P21333 | |
| SLLSDAAFNDSWSSF | 61 | Q9BT40 | |
| NIFAIFRQDSSSTGW | 86 | P01574 | |
| FSLFRDSQTLGLGWS | 226 | Q96P31 | |
| RFNGQYSSLALVTSW | 421 | Q4ZIN3 | |
| SSGLWNNTVFIFSTD | 286 | P15848 | |
| RSVFESNSDNWFLGR | 1386 | Q9ULL0 | |
| SDISNASSSFGWLSL | 791 | P22681 | |
| TAAFSNLSSLFDSQW | 166 | P20849 | |
| SASSLTGFSNWSAAI | 161 | Q17RY0 | |
| QSNEFGIFNSLWFSL | 581 | P42261 | |
| SSFWNQYAAALSNGL | 1231 | Q9NSC2 | |
| ALWSFNNSQFSDSDF | 1521 | Q9NZJ4 | |
| GSRSFLWAQTQADAA | 116 | P0C7U9 | |
| TSDSRFFNLWTLGLA | 21 | Q6W349 | |
| QTFNLFSTEDSSAAW | 86 | P01571 | |
| RGDKSFWNSASFNTE | 786 | Q96NU0 | |
| AASWISGFSNSVLQS | 146 | Q9GZK3 | |
| RSSWRNGGSLSFDAA | 986 | Q7Z6I6 | |
| WGLSFDSNLLSFSGR | 441 | Q96J94 | |
| SFFARDNTANFLSWC | 106 | O43903 | |
| WDSVQAFASSLSGSL | 96 | Q96GQ5 | |
| NVLNFTTSWTDGLAF | 171 | P46939 | |
| SWQFSSYVGRGLNSD | 501 | P52630 | |
| ASEEGWSQNSRSFRF | 436 | Q93075 | |
| ASSFHEFARNTSDAW | 56 | Q9NU19 | |
| FSNWTNSAFLAQGSL | 371 | P78414 | |
| SLRNEFWFSDGSLSD | 1541 | Q9P2F8 | |
| GSTTLQQWDDFSRFN | 211 | Q9UIF3 | |
| QTFNLFSTEDSSAAW | 86 | P05014 | |
| SLNDFASLSFAESWD | 36 | Q9GZT8 | |
| FRGLSFSFQLDSWTE | 131 | Q9BSU1 | |
| LQTFAFSVRWSDGSD | 21 | Q8NFA2 | |
| TTWRSGSSFFGELFN | 171 | Q9Y4C5 | |
| WRSGSSFLGQLFSQH | 71 | Q9GZS9 | |
| SRNLSAFFNWATSRA | 136 | Q9GZS9 | |
| LSSWRSGSSFVGQLF | 46 | Q9GZX3 | |
| YLNANSGSLSWSSDL | 216 | Q6ZU45 | |
| NLFGFWSRFNGSNSN | 421 | Q9H0M4 | |
| NGLRQSIWTNFSSRF | 361 | Q6P1M0 | |
| NLTGSFWNDSFARLS | 296 | Q15904 | |
| TNFTSSWKDGLAFNA | 196 | P11277 | |
| NSILNLFGSWLFDAA | 441 | Q86X10 | |
| WFQALNSSSESFGHN | 166 | Q8N0Z9 | |
| NNRSFFGWFSNHSSI | 346 | Q86VY4 | |
| TFQNKWSDQLSGFSL | 251 | Q9C0D4 |